fbpx Skip to main content
Category

Wet AMD

OphthalmologyWet AMD

Wet AMD Pipeline Therapies

Although anti-VEGF therapy has revolutionized care for wet age-related macular degeneration (AMD), real-world analyses have shown limited improvement in visual acuity over time, largely due to treatment burden. However, several pipeline therapies could reduce the…
November 4, 2021
OphthalmologyWet AMD

Genetic Polymorphism and Wet AMD

Anti-VEGF intravitreal injections are used to treat wet age-related macular degeneration (AMD). This meta-analysis, published in Ophthalmic Research, examined the available research on the genetic polymorphism of ARMS2 A69S conferring susceptibility to AMD with response to…
November 4, 2021
OphthalmologyWet AMD

Non-Viral Gene Therapy for Wet AMD

Anti-VEGF intravitreal injections are effective in treating wet age-related macular degeneration (AMD). However, longer-lasting anti-VEGF agents are needed to reduce the burden associated with intravitreal injections. This study, published in Investigative Ophthalmology & Visual Science, sought to…
October 25, 2021
OphthalmologyWet AMD

New Imaging Technique for Wet AMD

Optical coherence tomography angiography (OCT-A) is a new, non-invasive imaging technique used to evaluate retinal and choroidal microvasculature. This cross-sectional study, published in the Annals of Medicine and Surgery, sought to determine OCT-A's diagnostic accuracy in…
October 22, 2021